Invivyd to Host First Quarter 2025 Financial Results and Corporate Update Conference Call on May 15, 2025

Core Viewpoint - Invivyd, Inc. will host a conference call on May 15, 2025, to discuss its Q1 2025 financial results and recent business highlights [1]. Company Overview - Invivyd, Inc. is a biopharmaceutical company focused on providing protection against serious viral infectious diseases, starting with SARS-CoV-2 [3]. - The company utilizes a proprietary integrated technology platform that is unique in the industry for assessing, monitoring, developing, and adapting to create best-in-class antibodies [3]. - In March 2024, Invivyd received emergency use authorization (EUA) from the U.S. FDA for a monoclonal antibody in its pipeline of innovative antibody candidates [3].